4/19/11

Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.(Brief Article)(Statistical Data Included): An article from: Transplant News Reviews

Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.(Brief Article)(Statistical Data Included): An article from: Transplant News




This digital document is an article from Transplant News, published by Transplant Communications, Inc. on April 28, 2000. The length of the article is 340 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.(Brief Article)(Statistical Data Included)
Publication: Transplant News (Newsletter)
Date: April 28, 2000
Publisher: Transplant Communications, Inc.
Volume: 10 Issue: 8 Page: NA

Article Type: Brief Article, St





List Price: $ 5.95

Price: $ 5.95

Leukemia Problems Remedies | FIGHT CANCER INFO
Leukemia — Comprehensive overview covers symptoms, causes, risk factors, treatment of this blood-related cancer.
Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.(Brief Article)(Statistical Data Included): An article from: Transplant News

Stop Smoking Online
Optimized to Maximise Conversions. Great Conversions. Top Quality One Hour Stop Smoking Site. Low Refunds. Thousands are online right now looking for help. Claim your share of this enormous market.
Stop Smoking Online



Orignal From: Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.(Brief Article)(Statistical Data Included): An article from: Transplant News Reviews

No comments:

Post a Comment